# Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma

> **NCT05798455** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Tabriz University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** Sodium Pentaborate

## Key facts

- **NCT ID:** NCT05798455
- **Lead sponsor:** Tabriz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-05-22
- **Primary completion:** 2025-05-22
- **Final completion:** 2026-05-22
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05798455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05798455, "Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05798455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*